" At the time of the acquisition, Synergen had $125 million in cash, so assuming everything else in the company was irrelevant, the value one could place on GDNF was only $115 million."
AMGEN Paid in 1994 $115 Million for inferior compound compared to MANF $115M then = $375 Million to $575 Million now.